Leica Biosystems, a cancer diagnostics company and workflow solutions provider, and Indica Labs, a provider of computational and image management software in digital pathology, announced a partnership where they will focus on delivering compatible digital pathology workflow solutions.
The agreement establishes a cooperation between Leica Biosystems and Indica Labs with a commitment to maintain ongoing file format compatibility between Leica Biosystems Aperio GT 450 family of scanners with Indica Labs Halo family of software solutions, including AI-enabled image analysis and image management workflow software.
Leica Biosystems offers a comprehensive portfolio that spans the entire workflow from biopsy to diagnosis.
“The Indica team is delighted to formalize our relationship with Leica Biosystems. The partnership solidifies our commitment to ensuring that Leica Biosystems state-of-the art slide scanners, reagents, and instrumentation can be coupled with our leading digital workflow and analytics software,” says Steven Hashagen, CEO of Indica Labs. “Customers can rest assured that both companies are working proactively to meet the regulatory and technical integration needs of the industry.”
Indicia Labs’ flagship HALO and HALO AI platform facilitates quantitative evaluation of digital pathology images. HALO Link facilitates research-focused image management and collaboration while HALO AP enables collaborative clinical case review.
“For customers using Leica Biosystems Aperio GT 450 family platforms who are seeking AI-enabled image analysis and image management applications, this new partnership can eliminate integration challenges and provides our customers with peace of mind when implementing a digital pathology workflow with Indica’s HALO product portfolio,” says Gustavo Perez, president of Leica Biosystems.
